Human clinical trials of Teixobactin were estimated to be at least two years away, and one of the co-discoverers of the antibiotic estimated it would cost "in the low 100 millions" of dollars to develop a teixobactin drug over five or six years.
Human clinical trials of Teixobactin were estimated to be at least two years away. It would cost "in the low 100 millions" of dollars. This is to develop a teixobactin drug over five or six years. This was what one of the co-discoverers of the antibiotic estimated.